5AM dashes out of the gate, kicking off Q2 with $750M in two new funds
5AM Ventures is back — raising a behemoth of $750 million in two new funds to do what VCs do best.
The life sciences and biotech-focused VC announced the raise earlier this week, closing two funds worth $450 million and $300 million, respectively. Managing partner Andrew Schwab told Endpoints News that the two funds will be focused on different stage companies: the bigger one, known as 5AM Ventures VII, will invest in anywhere from 15-18 early-stage biotechs, including companies formed out of its internal incubation engine, 4:59.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.